Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic modulation by the tachykinins

P Rameshwar1, P Gascón

  • 1UMDNJ-New Jersey Medical School, Department of Medicine-Hematology, Newark 07103, USA. rameshwa@umdnj.edu

Acta Haematologica
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth.

Neoplasia (New York, N.Y.)·2025
Same author

Role of semaphorins, neuropilins and plexins in cancer progression.

Cancer letters·2024
Same author

Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter Study.

Ocular immunology and inflammation·2024
Same author

Acute macular neuroretinopathy after COVID-19 vaccine.

Journal francais d'ophtalmologie·2022
Same author

[Retinal arteriovenous communication: Report of two cases].

Journal francais d'ophtalmologie·2022
Same author

Role of en face OCT in following outer retinal folds after rhegmatogenous retinal detachment.

Journal francais d'ophtalmologie·2021
Same journal

Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes.

Acta haematologica·2026
Same journal

Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

Acta haematologica·2026
Same journal

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

Acta haematologica·2026
Same journal

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same journal

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Acta haematologica·2026
Same journal

Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

Acta haematologica·2026
See all related articles

Neuropeptides like Substance P (SP) and neurokinin-A (NK-A) modulate hematopoietic stem cell proliferation. These tachykinins interact with cytokine networks in bone marrow stroma to regulate blood cell production.

Area of Science:

  • Neuroscience
  • Immunology
  • Hematology

Background:

  • Neuropeptides, including tachykinins like Substance P (SP) and neurokinin-A (NK-A), are found in both neural and non-neural tissues, such as bone marrow.
  • SP and NK-A, derived from the preprotachykinin-I gene, act as immune and hematopoietic modulators.
  • These tachykinins interact with neurokinin receptors (NK-1R, NK-2R, NK-3R), with specific binding preferences for NK-1R (SP) and NK-2R (NK-A).

Purpose of the Study:

  • To investigate the role of tachykinins, SP and NK-A, in regulating hematopoietic progenitor cell proliferation.
  • To elucidate the mechanisms by which bone marrow stroma mediates the hematopoietic effects of tachykinins.
  • To understand the interplay between tachykinins, cytokines, and their receptors in the hematopoietic regulatory network.

Main Methods:

Related Experiment Videos

  • Studied the differential effects of SP and NK-A on myeloid progenitor (CFU-GM) proliferation.
  • Investigated the induction of cytokines by SP and NK-A in bone marrow stroma.
  • Analyzed intracellular signaling pathways mediated by NK-1R and NK-2R activation.

Main Results:

  • SP enhanced myeloid progenitor proliferation, correlating with increased levels of positive hematopoietic growth factors (e.g., IL-3, IL-6, GM-CSF).
  • NK-A inhibited myeloid progenitor proliferation, correlating with increased levels of negative regulators (e.g., MIP-1 alpha, TGF-beta).
  • Bone marrow stroma mediates these effects, partly through cytokine induction, and tachykinins can modulate receptor expression (NK-1R, IL-1 type I receptor).

Conclusions:

  • Tachykinins and cytokines are not mutually exclusive in regulating hematopoiesis; they interact in a complex network.
  • Hematopoietic regulation involves reciprocal induction of tachykinins and cytokines, cytokine-induced receptor expression, and tachykinin-induced cytokine receptor expression.
  • Neuropeptides play a crucial, often overlooked, role in the overall hematopoietic regulatory network.